Health Care · Electromedical & Electrotherapeutic Apparatus · Nasdaq · CIK 1861107 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $17.64Day −0.51%Mkt cap $673M1Y +18.2%Off 52W high −27.5%Vol (1Y) 55.0%
Daily closing price, split-adjusted to the current basis; 1.7y shown of 440 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.9% of sh out |
| Days to cover5.5d |
| 13F net flow (QoQ)+5.68% |
| Top-10 13F concentration63.8% |
| Next report (est.)2026-08-09 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$95.1M |
| Earnings (TTM)-$60.4M |
| ROE−30.8% |
| Net margin−60.0% |
| ROIC−82.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−19.6% |
| 1Y+18.2% |
| Since incept. (ann.)−17.6% |
Total return through 2026-07-30 · series begins 2024-10-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)55.0% |
| Ann. volatility (3Y)67.6% |
| Sharpe (1Y)0.62 |
| Sharpe (3Y)0.06 |
| Max drawdown (1Y)−30.5% |
| Max drawdown (3Y)−63.9% |
| Beta (3Y vs SPY)0.86 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| FMR LLC | 4.9M | $89M | 12.89% | +23.5% |
| TPG GP A, LLC | 4.0M | $73M | 10.54% | +0.0% |
| RED TREE MANAGEMENT, LLC | 2.2M | $40M | 5.86% | +0.0% |
| BlackRock, Inc. | 1.8M | $33M | 4.82% | −1.9% |
| KCM Capital Inc | 1.4M | $26M | 3.72% | +40.0% |
| Bank of New York Mellon Corp | 1.2M | $21M | 3.08% | −5.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $21M | 3.02% | new |
| FEDERATED HERMES, INC. | 939,464 | $17M | 2.50% | +19.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.52 | — | $26.5M | +29.3% |
| 2025-12-31 | 2026-02-24 | — | — | $24.8M | +33.7% |
| 2025-09-30 | 2025-11-04 | −$0.37 | — | $22.6M | +31.4% |
| 2025-06-30 | 2025-08-05 | −$0.38 | — | $21.2M | +38.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-09 is ESTIMATED from filing cadence (median gap 90d) — not company-confirmed.
Product 76% · Subscription 24%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
